Protective effects of pioglitazone in renal ischemia–reperfusion injury (RIRI): focus on oxidative stress and inflammation
Clinical and Experimental Nephrology · 2024-10 · 28 (10) · 955-968
DOI: 10.1007/s10157-024-02525-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Experimental Nephrology, online erschienen am 27.06.2024. Verfasst von Maryam Golmohammadi und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, 1988873554, Iran. Hauptthemen laut MEDLINE: Reperfusion Injury, Oxidative Stress, Pioglitazone, Acute Kidney Injury. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 159 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Renal ischemia-reperfusion injury (RIRI) is a critical phenomenon that compromises renal function and is the most serious health concern related to acute kidney injury (AKI). Pioglitazone (Pio) is a known agonist of peroxisome proliferator-activated receptor-gamma (PPAR-γ). PPAR-γ is a nuclear receptor that regulates genes involved in inflammation, metabolism, and cellular differentiation. Activation of PPAR-γ is associated with antiinflammatory and antioxidant effects, which are relevant to the pathophysiology of RIRI. This study aimed to investigate the protective effects of Pio in RIRI, focusing on oxidative stress and inflammation. METHODS: We conducted a comprehensive literature search using electronic databases, including PubMed, ScienceDirect, Web of Science, Scopus, and Google Scholar. RESULTS: The results of this study demonstrated that Pio has antioxidant, anti-inflammatory, and anti-apoptotic activities that counteract the consequences of RIRI. The study also discussed the underlying mechanisms, including the modulation of various pathways such as TNF-α, NF-κB signaling systems, STAT3 pathway, KIM-1 and NGAL pathways, AMPK phosphorylation, and autophagy flux. Additionally, the study presented a summary of various animal studies that support the potential protective effects of Pio in RIRI. CONCLUSION: Our findings suggest that Pio could protect the kidneys from RIRI by improving antioxidant capacity and decreasing inflammation. Therefore, these findings support the potential of Pio as a therapeutic strategy for preventing RIRI in different clinical conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, 1988873554, Iran.
- School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
- College of Pharmacy, Al-Bayan University, Baghdad, Iraq.
- Department of Physiology, Faculty of Medicine Lambung, Mangkurat University, South Kalimantan, Banjarmasin, Indonesia.
- Urology and Nephrology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran. mzamaniyan66@yahoo.com.
- Department of Physiology, Hamadan University of Medical Sciences, Hamadan, 6718773654, Iran. mzamaniyan66@yahoo.com.
Zitieren
APA
Golmohammadi, M., Ivraghi, M. S., Hasan, E. K., Huldani, H., Zamanian, M. Y., Rouzbahani, S., Mustafa, Y. F., Al-Hasnawi, S. S., Alazbjee, A. A. A., Khalajimoqim, F., & Khalaj, F. (2024). Protective effects of pioglitazone in renal ischemia–reperfusion injury (RIRI): focus on oxidative stress and inflammation. Clinical and Experimental Nephrology, 28(10), 955-968. https://doi.org/10.1007/s10157-024-02525-3
Vancouver
Golmohammadi M, Ivraghi MS, Hasan EK, Huldani H, Zamanian MY, Rouzbahani S, et al. Protective effects of pioglitazone in renal ischemia–reperfusion injury (RIRI): focus on oxidative stress and inflammation. Clinical and Experimental Nephrology. 2024;28(10):955-968. doi:10.1007/s10157-024-02525-3
BibTeX
@article{Golmohammadi2024,
author = {Golmohammadi, Maryam and Ivraghi, Mehraveh Sadeghi and Hasan, Ekhlas Khammas and Huldani, Huldani and Zamanian, Mohammad Yasin and Rouzbahani, Shiva and Mustafa, Yasser Fakri and Al-Hasnawi, Shaker Shanawa and Alazbjee, Adeeb Abdulally Abdulhussien and Khalajimoqim, Faranak and Khalaj, Fattaneh},
title = {Protective effects of pioglitazone in renal ischemia–reperfusion injury (RIRI): focus on oxidative stress and inflammation},
journal = {Clinical and Experimental Nephrology},
year = {2024},
volume = {28},
number = {10},
pages = {955--968},
doi = {10.1007/s10157-024-02525-3}
}
EUVIMED